about
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and ...
Read More
1.97
-0.10
(-4.83%)
676.5K
XNAS Volume
XNAS 12 Sep, 2025 4:00 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Nkarta Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..